Cannabis & Blood Pressure: Acute vs. Chronic Effects
Cannabis exerts complex, dose-dependent, and time-dependent effects on blood pressure (BP). Acute use typically lowers BP; chronic heavy use may elevate it. Individual variability is high.
Acute Effects (Minutes to Hours)
- Vasodilation: THC activates CB1 receptors on vascular endothelium → nitric oxide release → arterial dilation → ↓ BP (5–15 mmHg systolic).
- Tachycardia: Reflex sympathetic activation (baroreflex) → heart rate ↑ 20–50 bpm.
- Postural hypotension: Impaired baroreflex + vasodilation → orthostatic dizziness/syncope (especially elderly, volume-depleted).
- Peak effect: 10–30 min post-inhalation; lasts 1–3 hrs.
Chronic Effects (Weeks to Years)
- Epidemiological data: Cross-sectional studies associate daily cannabis use with higher systolic BP and hypertension prevalence (OR 1.3–1.5).
- Mechanisms proposed:
- CB1-mediated sympathetic overactivity
- Renin-angiotensin-aldosterone system (RAAS) dysregulation
- Endothelial dysfunction from oxidative stress
- Weight gain (munchies) → metabolic syndrome
- Sleep architecture disruption
- Tolerance: Develops to acute hemodynamic effects (tachycardia, hypotension) but not necessarily to long-term vascular changes.
Dose-Response Relationship
- Occasional/low-dose: Neutral or transient BP reduction.
- Heavy daily use (≥1 joint/day or equivalent): Associated with sustained BP elevation.
- Route matters: Inhalation → rapid peak; edibles → delayed, prolonged, sometimes stronger hemodynamic effects.
Cannabinoid-Specific Effects
| Compound | Primary Cardiovascular Effect |
|---|---|
| THC (Δ⁹-THC) | CB1 agonist → vasodilation, tachycardia, hypotension (acute); possible sympathetic upregulation (chronic) |
| CBD (Cannabidiol) | Non-CB1; may ↓ BP via anxiolysis, vasorelaxation (PPARγ, 5-HT1A); no tachycardia |
| THCV | CB1 antagonist at low dose → may mitigate THC effects; under study |
